Tissue plasminogen activator induced by dengue virus infection of human endothelial cells

被引:42
作者
Huang, YH
Lei, HY
Liu, HS
Lin, YS
Chen, SH
Liu, CC
Yeh, TM [1 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Med Technol, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan
关键词
dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS); fibrinolysis; tissue plasminogen activator (tPA); plasminogen activator inhibitor-1 (PAI-1);
D O I
10.1002/jmv.10438
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are severe complications of dengue virus (DV) infection. However, the pathogenesis of hemorrhage induced by dengue virus infection is poorly understood. Since endothelial cells play a pivotal role in the regulation of hemostasis, we studied the effect of DV infection on the production of tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) in vitro using both primary isolated endothelial cells, human umbilical cord veins cells, and a human microvascular endothelial cell line. DV infection significantly induced the secretion of tPA but not PAI-1 of human endothelial cells. In addition, tPA mRNA of endothelial cells was induced by DV as demonstrated by RT-PCR. Antibody against IL-6 but not control antibody inhibited DV-induced tPA production of endothelial cells. Furthermore, a good correlation between sera levels of IL-6 and tPA was found in DHF but not DF patients. These results suggest that IL-6 can regulate DV-induced tPA production of endothelial cells, which may play important roles in the pathogenic development of DHF/DSS. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:610 / 616
页数:7
相关论文
共 33 条
[1]   HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[2]  
Avirutnan P, 1998, J IMMUNOL, V161, P6338
[3]   TISSUE PLASMINOGEN-ACTIVATOR - CHEMICAL AND PHYSIOLOGICAL-ASPECTS [J].
BACHMANN, F ;
KRUITHOF, IEKO .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) :6-17
[4]  
BHAMGARAPRAVATI N, 1989, REV INFECT DIS S4, V1, pS826
[5]   Hemorrhagic fever virus-induced changes in hemostasis and vascular biology [J].
Chen, JP ;
Cosgriff, TM .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (05) :461-483
[6]  
DICHEK D, 1989, BLOOD, V74, P222
[7]  
Duchini A, 1996, J INVEST MED, V44, P474
[8]  
EMEIS JJ, 1995, FIBRINOLYSIS DIS, P55
[9]   HORMONAL-REGULATION OF HEMOSTASIS AND THE MOLECULAR-BIOLOGY OF THE FIBRINOLYTIC SYSTEM [J].
GRANT, PJ ;
MEDCALF, RL .
CLINICAL SCIENCE, 1990, 78 (01) :3-11
[10]   Dengue and dengue hemorrhagic fever [J].
Gubler, DJ .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :480-+